|
|
| | TAK-659 Basic information |
| Product Name: | TAK-659 | | Synonyms: | TAK-659;6-((1R,2S)-2-Aminocyclohexylamino)-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-c]pyridin-3(2H)-one;Tak-659 free base;Mivavotinib;MIVAVOTINIB;TAK 659;TAK659;3H-Pyrrolo[3,4-c]pyridin-3-one, 6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-1,2-dihydro-4-(1-methyl-1H-pyrazol-4-yl)-;TAK-659 free base(Mivavotinib) | | CAS: | 1312691-33-0 | | MF: | C17H21FN6O | | MW: | 344.39 | | EINECS: | 604-604-1 | | Product Categories: | | | Mol File: | 1312691-33-0.mol |  |
| | TAK-659 Chemical Properties |
| Boiling point | 661.7±55.0 °C(Predicted) | | density | 1.58±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 10.90±0.20(Predicted) |
| | TAK-659 Usage And Synthesis |
| Uses | Mivavotinib is employed in the discovery of Lanraplenib, a tyrosine kinase inhibitor for autoimmune diseases. |
| | TAK-659 Preparation Products And Raw materials |
|